Administer tranexamic acid early to injured patients at risk of substantial bleeding

BMJ (Online)

Volumn 345, Issue 7884, 2012, Pages

  Gruen, Russell L ^a,b   Reade, Michael C ^c,d,e  

^a MONASH UNIVERSITY   (Australia)

^b NATIONAL TRAUMA RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d School of Engineering and Information Technology   (Australia)

^e ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TRANEXAMIC ACID;

ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; DOSAGE SCHEDULE COMPARISON; DRUG RESPONSE; ELECTIVE SURGERY; HUMAN; INJURY; LOADING DRUG DOSE; LUNG EMBOLISM; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; THROMBOSIS; UNITED KINGDOM;

ANTIFIBRINOLYTIC AGENTS; EARLY MEDICAL INTERVENTION; HEMORRHAGE; HUMANS; RISK FACTORS; TRANEXAMIC ACID; WOUNDS AND INJURIES;

EID: 84869771520     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e7133     Document Type: Article

References (14)

1. Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma 2006;60:S3-11.
2. Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma 2003;54:1127-30. (Pubitemid 36764882)
3. Kashuk JL, Moore EE, Sawyer M, Wohlauer M, Pezold M, Barnett C, et al. Primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma. Ann Surg 2010;252:434-42.
4. Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ 2012;344:e3054.
5. Roberts I, Shakur H, Ker K, Coats T, on behalf of the CRASH-2 trial collaborators. Antifibrinolytic drugs for acute traumatic injury. Cochrane Database Syst Rev 2011;1:CD004896.
6. Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010;376:23-32.
7. Roberts I, Perel P, Prieto-Merino D, Shakur H, Coats T, Hunt BJ, et al. Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomised controlled trial. BMJ 2012:345:e5839.
8. Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011 Mar 26;377:1096-101.
9. Ker K, Kiriya J, Perel P, Edwards P, Shakur H, Roberts I. Avoidable mortality from giving tranexamic acid to bleeding trauma patients: an estimation based on WHO mortality data, a systematic literature review and data from the CRASH-2 trial. BMC Emerg Med 2012;12:3.
10. Guerriero C, Cairns J, Perel P, Shakur H, Roberts I. Cost-effectiveness analysis of administering tranexamic acid to bleeding trauma patients using evidence from the CRASH-2 trial. PLoS One 2011;6:e18987.
11. Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ. Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study. Arch Surg 2012;147:113-9.
12. Ioannidis JPA. Contradicted and initially stronger effects in highly cited clinical research. JAMA 2005;294:218-28. (Pubitemid 41043792)
13. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699-709. (Pubitemid 32204987)
14. Gruen RL, Brohi K, Schreiber M, Balogh Z, Pitt V, Narayan M, et al. Haemorrhage control in severely injured patients. Lancet 2012;380:1099-108.